Yapay Zeka Hızlı Bakış & Çıkarımlar
AI InsightTRPA1 may be a potential drug targetto inhibit the development of duodenal lesions by stress-induced in patients.
📌 3 Maddede Bu Makale
Özet
Background/Aims: Transient receptor potential ankyrin 1 (TRPA1) and substance P (SP), both expression in sensory neurons, have important roles in stress-induced duodenal lesions. The possible contribution of TRPA1 and SP to stress-induced duodenal lesions wasexplored by using the water immersion restraint stress (WIRS) rat model.Materials and Methods: Western blotting, Real-time polymerase chain reaction (RT-PCR), and immunohistochemistry assay were usedto evaluate the changes of TRPA1and SP expression in the dorsal root ganglia (DRG, T8-11), the corresponding segment of the spinalcord (T8-11), and the duodenum in a duodenal lesions rat model. The SP concentrations of duodenal mucosa were investigated using anenzyme-linked immunosorbent assay (ELISA). Duodenal lesions were assessed according to histopathological changes. TRPA1 specificantagonist HC-030031 was intrathecally or intraperitoneally performed to suppress the expression of both TRPA1 and SP for evaluatingthe roles of TRPA1 and SP in duodenal lesions.Results: In contrast to the control group, TRPA1 and substance P in the DRG (T8-11) and duodenum were up-regulated, and concentrations of SP in the duodenal mucosa were increased after WIRS (p 0.05).Conclusion: Our study indicates that TRPA1 antagonist HC-030031 alleviates duodenal lesions. TRPA1 is activated and sensitized,therefore concomitant neuropeptide SP is released, which exerts a critical role in inducing and maintaining duodenal lesions followingWIRS in rats. This provides evidence that neuroimmune interactions may control duodenal injury. TRPA1 may be a potential drug targetto inhibit the development of duodenal lesions by stress-induced in patients.